Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Evaluation of Retinol Palmitate Administration and Serum Levels in Preterm Infants with Bronchopulmonary Dysplasia: A Phase 2a Open-Label Study

    Not recruiting

    2 1 1
    Investigated Drugs:
    Germany Poland
  • Efficacy and Safety of Maintenance Cabozantinib Plus Best Supportive Care in Pediatric and AYA Patients with Unresectable Residual Osteosarcoma

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    Austria Belgium Denmark France Germany Ireland +5
  • A Study of Leniolisib Safety and Effectiveness for Immune System Problems in Patients with Common Variable Immunodeficiency

    Not recruiting

    2 1 1
    Investigated Drugs:
    Spain
  • Study of nedosiran for patients with primary hyperoxaluria type 1 and severe kidney impairment with or without dialysis

    Not recruiting

    2 1 1
    Investigated Drugs:
    Germany Italy Spain
  • A Study of Erenumab Compared to Placebo for Children and Teenagers With Chronic Migraine to Test How Well It Works and How Safe It Is

    Not recruiting

    3 1
    Investigated Drugs:
    Belgium Germany Hungary Italy Poland
  • Study of Erenumab Compared to Placebo for Children and Adolescents with Episodic Migraine to Reduce Monthly Migraine Days

    Not recruiting

    3 1
    Investigated Drugs:
    Belgium Germany Hungary Italy Poland Portugal +1
  • A Study of KT-621 Tablets Taken by Mouth for Adults with Moderate to Severe Atopic Dermatitis

    Not recruiting

    2 1
    Czechia Germany Poland
  • A study testing how well zodasiran works and how safe it is for teenagers and adults with homozygous familial hypercholesterolemia

    Not recruiting

    3 1
    Investigated Drugs:
    Austria Belgium Czechia France Germany Greece +4
  • A study looking at the safety of switching from emicizumab to denecimig in adults and adolescents with haemophilia A with or without inhibitors

    Not recruiting

    3 1 1
    Austria Belgium France Germany Italy Spain
  • A study testing the safety and how the body processes TAK-861 in children and teenagers aged 6 to 17 years with narcolepsy type 1

    Not recruiting

    1 1 1
    Investigated Diseases:
    Italy